Dr Harvey Alter and others published an article entitled "The Ausria Test: Critical Evaluation of Sensitivity and Specificity" to study measures of donor screening for Hepatitis B antigen. The authors emphasised that "by far, the single most significant measure for the reduction of posttransfusion hepatitis is the total exclusion of the commercial donor."